|
09.04.2019 08:42:00
|
Karo Pharma Publishes the 2018 Annual Report
HUDDINGE, Sweden, April 9, 2019 /PRNewswire/ --
Karo Pharma publishes its annual report for 2018.
Today, on 9 April 2019, Karo Pharma is publishing its annual report for 2018 on the company's website, www.karopharma.com.
FOR ADDITIONAL INFORMATION, PLEASE CONTACT:
Mats-Olof Wallin, CFO, +4676 002 60 10, mats-olof.wallin@karopharma.se
ABOUT KARO PHARMA
Karo Pharma is a Specialty Pharma company, which develops and markets products for pharmacies as well as directly to the healthcare sector. Karo Pharma is listed on Nasdaq Stockholm Mid Cap.
This information is information that Karo Pharma is obliged to make public pursuant to the Swedish Securities Market Act. The information was submitted for publication, through the agency of the contact person set out above, on 9 April, at 08:30 CEST. This press release is also available at www.karopharma.seand www.newsroom.cision.com.
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/karo-pharma/r/karo-pharma-publishes-the-2018-annual-report,c2783507
The following files are available for download:
https://mb.cision.com/Main/72/2783507/1022182.pdf | Karo Pharma Annual Report 2018 (PDF) |
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Karo Pharma ABmehr Nachrichten
| Keine Nachrichten verfügbar. |
Analysen zu Karo Pharma ABmehr Analysen
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.